Global Pseudoephedrine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Pseudoephedrine market report explains the definition, types, applications, major countries, and major players of the Pseudoephedrine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • CVS Caremark

    • Cypress Pharma

    • UCB Inc

    • Pfizer (Wyeth)

    • Zhuhai Tianda Pharma

    • Ratiopharm (Teva)

    • Apotec

    • Hanmi

    • Merck

    • Endo International

    • Pacific Pharmal

    • Sanofi

    • Johnson & Johnson

    • Sun Pharmaceutical

    • Kroger Company

    • Sichuan Shenghe Pharmaceutical

    By Type:

    • Active Pharmaceutical Ingredients

    • Preparation

    By End-User:

    • Sinusitis

    • Congestive Rhinitis

    • Bronchial Asthma

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pseudoephedrine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pseudoephedrine Outlook to 2028- Original Forecasts

    • 2.2 Pseudoephedrine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pseudoephedrine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pseudoephedrine Market- Recent Developments

    • 6.1 Pseudoephedrine Market News and Developments

    • 6.2 Pseudoephedrine Market Deals Landscape

    7 Pseudoephedrine Raw Materials and Cost Structure Analysis

    • 7.1 Pseudoephedrine Key Raw Materials

    • 7.2 Pseudoephedrine Price Trend of Key Raw Materials

    • 7.3 Pseudoephedrine Key Suppliers of Raw Materials

    • 7.4 Pseudoephedrine Market Concentration Rate of Raw Materials

    • 7.5 Pseudoephedrine Cost Structure Analysis

      • 7.5.1 Pseudoephedrine Raw Materials Analysis

      • 7.5.2 Pseudoephedrine Labor Cost Analysis

      • 7.5.3 Pseudoephedrine Manufacturing Expenses Analysis

    8 Global Pseudoephedrine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pseudoephedrine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pseudoephedrine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pseudoephedrine Market Outlook by Types and Applications to 2022

    • 9.1 Global Pseudoephedrine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Active Pharmaceutical Ingredients Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Preparation Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pseudoephedrine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Sinusitis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Congestive Rhinitis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Bronchial Asthma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pseudoephedrine Market Analysis and Outlook till 2022

    • 10.1 Global Pseudoephedrine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pseudoephedrine Consumption (2017-2022)

      • 10.2.2 Canada Pseudoephedrine Consumption (2017-2022)

      • 10.2.3 Mexico Pseudoephedrine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pseudoephedrine Consumption (2017-2022)

      • 10.3.2 UK Pseudoephedrine Consumption (2017-2022)

      • 10.3.3 Spain Pseudoephedrine Consumption (2017-2022)

      • 10.3.4 Belgium Pseudoephedrine Consumption (2017-2022)

      • 10.3.5 France Pseudoephedrine Consumption (2017-2022)

      • 10.3.6 Italy Pseudoephedrine Consumption (2017-2022)

      • 10.3.7 Denmark Pseudoephedrine Consumption (2017-2022)

      • 10.3.8 Finland Pseudoephedrine Consumption (2017-2022)

      • 10.3.9 Norway Pseudoephedrine Consumption (2017-2022)

      • 10.3.10 Sweden Pseudoephedrine Consumption (2017-2022)

      • 10.3.11 Poland Pseudoephedrine Consumption (2017-2022)

      • 10.3.12 Russia Pseudoephedrine Consumption (2017-2022)

      • 10.3.13 Turkey Pseudoephedrine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pseudoephedrine Consumption (2017-2022)

      • 10.4.2 Japan Pseudoephedrine Consumption (2017-2022)

      • 10.4.3 India Pseudoephedrine Consumption (2017-2022)

      • 10.4.4 South Korea Pseudoephedrine Consumption (2017-2022)

      • 10.4.5 Pakistan Pseudoephedrine Consumption (2017-2022)

      • 10.4.6 Bangladesh Pseudoephedrine Consumption (2017-2022)

      • 10.4.7 Indonesia Pseudoephedrine Consumption (2017-2022)

      • 10.4.8 Thailand Pseudoephedrine Consumption (2017-2022)

      • 10.4.9 Singapore Pseudoephedrine Consumption (2017-2022)

      • 10.4.10 Malaysia Pseudoephedrine Consumption (2017-2022)

      • 10.4.11 Philippines Pseudoephedrine Consumption (2017-2022)

      • 10.4.12 Vietnam Pseudoephedrine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pseudoephedrine Consumption (2017-2022)

      • 10.5.2 Colombia Pseudoephedrine Consumption (2017-2022)

      • 10.5.3 Chile Pseudoephedrine Consumption (2017-2022)

      • 10.5.4 Argentina Pseudoephedrine Consumption (2017-2022)

      • 10.5.5 Venezuela Pseudoephedrine Consumption (2017-2022)

      • 10.5.6 Peru Pseudoephedrine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pseudoephedrine Consumption (2017-2022)

      • 10.5.8 Ecuador Pseudoephedrine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pseudoephedrine Consumption (2017-2022)

      • 10.6.2 Kuwait Pseudoephedrine Consumption (2017-2022)

      • 10.6.3 Oman Pseudoephedrine Consumption (2017-2022)

      • 10.6.4 Qatar Pseudoephedrine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pseudoephedrine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pseudoephedrine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pseudoephedrine Consumption (2017-2022)

      • 10.7.2 South Africa Pseudoephedrine Consumption (2017-2022)

      • 10.7.3 Egypt Pseudoephedrine Consumption (2017-2022)

      • 10.7.4 Algeria Pseudoephedrine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pseudoephedrine Consumption (2017-2022)

      • 10.8.2 New Zealand Pseudoephedrine Consumption (2017-2022)

    11 Global Pseudoephedrine Competitive Analysis

    • 11.1 CVS Caremark

      • 11.1.1 CVS Caremark Company Details

      • 11.1.2 CVS Caremark Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 CVS Caremark Pseudoephedrine Main Business and Markets Served

      • 11.1.4 CVS Caremark Pseudoephedrine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Cypress Pharma

      • 11.2.1 Cypress Pharma Company Details

      • 11.2.2 Cypress Pharma Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Cypress Pharma Pseudoephedrine Main Business and Markets Served

      • 11.2.4 Cypress Pharma Pseudoephedrine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 UCB Inc

      • 11.3.1 UCB Inc Company Details

      • 11.3.2 UCB Inc Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 UCB Inc Pseudoephedrine Main Business and Markets Served

      • 11.3.4 UCB Inc Pseudoephedrine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Pfizer (Wyeth)

      • 11.4.1 Pfizer (Wyeth) Company Details

      • 11.4.2 Pfizer (Wyeth) Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Pfizer (Wyeth) Pseudoephedrine Main Business and Markets Served

      • 11.4.4 Pfizer (Wyeth) Pseudoephedrine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Zhuhai Tianda Pharma

      • 11.5.1 Zhuhai Tianda Pharma Company Details

      • 11.5.2 Zhuhai Tianda Pharma Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Zhuhai Tianda Pharma Pseudoephedrine Main Business and Markets Served

      • 11.5.4 Zhuhai Tianda Pharma Pseudoephedrine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Ratiopharm (Teva)

      • 11.6.1 Ratiopharm (Teva) Company Details

      • 11.6.2 Ratiopharm (Teva) Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Ratiopharm (Teva) Pseudoephedrine Main Business and Markets Served

      • 11.6.4 Ratiopharm (Teva) Pseudoephedrine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Apotec

      • 11.7.1 Apotec Company Details

      • 11.7.2 Apotec Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Apotec Pseudoephedrine Main Business and Markets Served

      • 11.7.4 Apotec Pseudoephedrine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Hanmi

      • 11.8.1 Hanmi Company Details

      • 11.8.2 Hanmi Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Hanmi Pseudoephedrine Main Business and Markets Served

      • 11.8.4 Hanmi Pseudoephedrine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Merck

      • 11.9.1 Merck Company Details

      • 11.9.2 Merck Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Merck Pseudoephedrine Main Business and Markets Served

      • 11.9.4 Merck Pseudoephedrine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Endo International

      • 11.10.1 Endo International Company Details

      • 11.10.2 Endo International Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Endo International Pseudoephedrine Main Business and Markets Served

      • 11.10.4 Endo International Pseudoephedrine Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Pacific Pharmal

      • 11.11.1 Pacific Pharmal Company Details

      • 11.11.2 Pacific Pharmal Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Pacific Pharmal Pseudoephedrine Main Business and Markets Served

      • 11.11.4 Pacific Pharmal Pseudoephedrine Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Sanofi

      • 11.12.1 Sanofi Company Details

      • 11.12.2 Sanofi Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Sanofi Pseudoephedrine Main Business and Markets Served

      • 11.12.4 Sanofi Pseudoephedrine Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Johnson & Johnson

      • 11.13.1 Johnson & Johnson Company Details

      • 11.13.2 Johnson & Johnson Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Johnson & Johnson Pseudoephedrine Main Business and Markets Served

      • 11.13.4 Johnson & Johnson Pseudoephedrine Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Sun Pharmaceutical

      • 11.14.1 Sun Pharmaceutical Company Details

      • 11.14.2 Sun Pharmaceutical Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Sun Pharmaceutical Pseudoephedrine Main Business and Markets Served

      • 11.14.4 Sun Pharmaceutical Pseudoephedrine Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Kroger Company

      • 11.15.1 Kroger Company Company Details

      • 11.15.2 Kroger Company Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Kroger Company Pseudoephedrine Main Business and Markets Served

      • 11.15.4 Kroger Company Pseudoephedrine Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 Sichuan Shenghe Pharmaceutical

      • 11.16.1 Sichuan Shenghe Pharmaceutical Company Details

      • 11.16.2 Sichuan Shenghe Pharmaceutical Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 Sichuan Shenghe Pharmaceutical Pseudoephedrine Main Business and Markets Served

      • 11.16.4 Sichuan Shenghe Pharmaceutical Pseudoephedrine Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    12 Global Pseudoephedrine Market Outlook by Types and Applications to 2028

    • 12.1 Global Pseudoephedrine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Active Pharmaceutical Ingredients Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Preparation Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pseudoephedrine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Sinusitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Congestive Rhinitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Bronchial Asthma Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pseudoephedrine Market Analysis and Outlook to 2028

    • 13.1 Global Pseudoephedrine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pseudoephedrine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.2 UK Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.5 France Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pseudoephedrine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.4.3 India Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pseudoephedrine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pseudoephedrine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pseudoephedrine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pseudoephedrine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pseudoephedrine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pseudoephedrine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pseudoephedrine

    • Figure of Pseudoephedrine Picture

    • Table Global Pseudoephedrine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pseudoephedrine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Active Pharmaceutical Ingredients Consumption and Growth Rate (2017-2022)

    • Figure Global Preparation Consumption and Growth Rate (2017-2022)

    • Figure Global Sinusitis Consumption and Growth Rate (2017-2022)

    • Figure Global Congestive Rhinitis Consumption and Growth Rate (2017-2022)

    • Figure Global Bronchial Asthma Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Pseudoephedrine Consumption by Country (2017-2022)

    • Table North America Pseudoephedrine Consumption by Country (2017-2022)

    • Figure United States Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Canada Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Table Europe Pseudoephedrine Consumption by Country (2017-2022)

    • Figure Germany Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure UK Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Spain Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure France Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Italy Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Finland Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Norway Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Poland Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Russia Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Table APAC Pseudoephedrine Consumption by Country (2017-2022)

    • Figure China Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Japan Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure India Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Table South America Pseudoephedrine Consumption by Country (2017-2022)

    • Figure Brazil Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Chile Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Peru Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Table GCC Pseudoephedrine Consumption by Country (2017-2022)

    • Figure Bahrain Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Oman Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Table Africa Pseudoephedrine Consumption by Country (2017-2022)

    • Figure Nigeria Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Table Oceania Pseudoephedrine Consumption by Country (2017-2022)

    • Figure Australia Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pseudoephedrine Consumption and Growth Rate (2017-2022)

    • Table CVS Caremark Company Details

    • Table CVS Caremark Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CVS Caremark Pseudoephedrine Main Business and Markets Served

    • Table CVS Caremark Pseudoephedrine Product Portfolio

    • Table Cypress Pharma Company Details

    • Table Cypress Pharma Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cypress Pharma Pseudoephedrine Main Business and Markets Served

    • Table Cypress Pharma Pseudoephedrine Product Portfolio

    • Table UCB Inc Company Details

    • Table UCB Inc Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table UCB Inc Pseudoephedrine Main Business and Markets Served

    • Table UCB Inc Pseudoephedrine Product Portfolio

    • Table Pfizer (Wyeth) Company Details

    • Table Pfizer (Wyeth) Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer (Wyeth) Pseudoephedrine Main Business and Markets Served

    • Table Pfizer (Wyeth) Pseudoephedrine Product Portfolio

    • Table Zhuhai Tianda Pharma Company Details

    • Table Zhuhai Tianda Pharma Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zhuhai Tianda Pharma Pseudoephedrine Main Business and Markets Served

    • Table Zhuhai Tianda Pharma Pseudoephedrine Product Portfolio

    • Table Ratiopharm (Teva) Company Details

    • Table Ratiopharm (Teva) Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ratiopharm (Teva) Pseudoephedrine Main Business and Markets Served

    • Table Ratiopharm (Teva) Pseudoephedrine Product Portfolio

    • Table Apotec Company Details

    • Table Apotec Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotec Pseudoephedrine Main Business and Markets Served

    • Table Apotec Pseudoephedrine Product Portfolio

    • Table Hanmi Company Details

    • Table Hanmi Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hanmi Pseudoephedrine Main Business and Markets Served

    • Table Hanmi Pseudoephedrine Product Portfolio

    • Table Merck Company Details

    • Table Merck Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Pseudoephedrine Main Business and Markets Served

    • Table Merck Pseudoephedrine Product Portfolio

    • Table Endo International Company Details

    • Table Endo International Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Endo International Pseudoephedrine Main Business and Markets Served

    • Table Endo International Pseudoephedrine Product Portfolio

    • Table Pacific Pharmal Company Details

    • Table Pacific Pharmal Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pacific Pharmal Pseudoephedrine Main Business and Markets Served

    • Table Pacific Pharmal Pseudoephedrine Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pseudoephedrine Main Business and Markets Served

    • Table Sanofi Pseudoephedrine Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Pseudoephedrine Main Business and Markets Served

    • Table Johnson & Johnson Pseudoephedrine Product Portfolio

    • Table Sun Pharmaceutical Company Details

    • Table Sun Pharmaceutical Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Pseudoephedrine Main Business and Markets Served

    • Table Sun Pharmaceutical Pseudoephedrine Product Portfolio

    • Table Kroger Company Company Details

    • Table Kroger Company Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kroger Company Pseudoephedrine Main Business and Markets Served

    • Table Kroger Company Pseudoephedrine Product Portfolio

    • Table Sichuan Shenghe Pharmaceutical Company Details

    • Table Sichuan Shenghe Pharmaceutical Pseudoephedrine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sichuan Shenghe Pharmaceutical Pseudoephedrine Main Business and Markets Served

    • Table Sichuan Shenghe Pharmaceutical Pseudoephedrine Product Portfolio

    • Figure Global Active Pharmaceutical Ingredients Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Preparation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sinusitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Congestive Rhinitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bronchial Asthma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pseudoephedrine Consumption Forecast by Country (2022-2028)

    • Table North America Pseudoephedrine Consumption Forecast by Country (2022-2028)

    • Figure United States Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pseudoephedrine Consumption Forecast by Country (2022-2028)

    • Figure Germany Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pseudoephedrine Consumption Forecast by Country (2022-2028)

    • Figure China Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pseudoephedrine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pseudoephedrine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pseudoephedrine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pseudoephedrine Consumption Forecast by Country (2022-2028)

    • Figure Australia Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pseudoephedrine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.